|
| 产品描述 |
| Cobimetinib, also known as GDC-0973 and XL-518 , is an orally bioavailable small-molecule inhibitor of mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), with potential antineoplastic activity. MEK inhibitor GDC-0973 specifically binds to and inhibits the catalytic activity of MEK1, resulting in inhibition of extracellular signal-related kinase 2 (ERK2) phosphorylation and activation and decreased tumor cell proliferation. Preclinical studies have demonstrated that this agent is effective in inhibiting the growth of tumor cells bearing a B-RAF mutation, which has been found to be associated with many tumor types. |
| 化学结构 |
 |
| 化学名称 |
| (S)-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)(3-hydroxy-3-(piperidin-2-yl)cyclobutyl)methanone. |
| SMILES Code |
| O=C(C1=CC=C(F)C(F)=C1NC2=CC=C(I)C=C2F)C3CC([C@H]4NCCCC4)(O)C3 |
| 基本信息 |
产品编号:XM381
产品名称:Cobimetinib
别名:XL518; XL 518; XL-518; GDC0973; GDC 0973; GDC-0973; cobimetinib
CAS#:934660-93-2 (free base)
分子式:C22H22F3IN2O2
精确分子量:530.06781
分子量:530.32196
|
| 物化性质 |
外观: 白色固体粉末
纯度: >98%
运输信息: 非危险化学品，适于常温或冰袋运输。
储存条件: 低温，干燥，避光。
溶解性: 溶于DMSO, 不溶于水
储存期限:3年 -20℃固体储存
2 年 -80℃ 溶液储存 |
该产品只供科研使用，不能给病人提供。
|
|
|
